Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00982007 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)
A Phase 3 study, sponsored by American Regent.
- Completed
- Registry status
- Phase 3
- Development phase
- 997
- Enrollment target
NCT00982007: Completed Phase 3 study, sponsored by American Regent.
NCT00982007 is a Phase 3 study that has completed, run by American Regent. The registered enrollment target is 997 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (29% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00982007, a Phase 3 study, has completed, sponsored by American Regent.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 997 participants
- Enrollment target
Study Summary
The main objective of this study is to demonstrate the efficacy and safety of an investigational intravenous (IV) iron, ferric carboxymaltose (FCM), compared to oral iron in subjects who have iron deficiency anemia (IDA) and have shown an unsatisfactory response to oral iron.
Interventions
- DRUG IV Iron (standard of care)
- DRUG Ferric Carboxymaltose (FCM)
- DRUG Ferrous Sulfate Tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 997 participants |
| Start Date | 2009-09 |
| Est. Completion | 2011-08 |
| Phase | Phase 3 |
What the finished NCT00982007 record still lists
NCT00982007 is an interventional study that assigns participants to a tested intervention. The registered 997 participants enrollment target is mid-sized for trials with a published cap, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (29% higher).
The record links to 0 conditions, and to 3 interventions - of which IV Iron (standard of care) is the first listed.
NCT00982007 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00982007 about?
NCT00982007 is a clinical study titled "Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)". The main objective of this study is to demonstrate the efficacy and safety of an investigational intravenous (IV) iron, ferric carboxymaltose (FCM), compared to oral iron in subjects who have iron deficiency anemia (IDA) and have shown an unsatisfactory response to oral iron.
What is the current status of trial NCT00982007?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 997 participants. The study started on 2009-09. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00982007?
The interventions under investigation include: IV Iron (standard of care) (DRUG), Ferric Carboxymaltose (FCM) (DRUG), Ferrous Sulfate Tablets (DRUG).
Who is sponsoring clinical trial NCT00982007?
This trial is sponsored by American Regent, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00982007's enrollment target sits among peer trials
997 312th of 2000 higher than 1,689 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07005024 · 996 participants · Phase 3
DOAC - Dosing Options in AntiCoagulation Prophylaxis
- NCT02986048 · 999 participants
Proton Therapy Patient Registry
- NCT04703244 · 999 participants
Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia